Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 01 04:00PM ET
6.59
Dollar change
+0.23
Percentage change
3.62
%
Index- P/E- EPS (ttm)-2.55 Insider Own31.35% Shs Outstand34.96M Perf Week35.60%
Market Cap291.87M Forward P/E- EPS next Y-1.38 Insider Trans0.04% Shs Float30.41M Perf Month72.97%
Income-94.29M PEG- EPS next Q-0.47 Inst Own28.67% Short Float4.20% Perf Quarter323.79%
Sales0.00M P/S- EPS this Y46.35% Inst Trans-1.98% Short Ratio2.02 Perf Half Y212.32%
Book/sh3.11 P/B2.12 EPS next Y29.73% ROA-45.93% Short Interest1.28M Perf Year172.31%
Cash/sh3.04 P/C2.17 EPS next 5Y34.60% ROE-57.73% 52W Range1.35 - 6.92 Perf YTD266.11%
Dividend Est.- P/FCF- EPS past 5Y- ROI-59.54% 52W High-4.77% Beta1.63
Dividend TTM- Quick Ratio4.91 Sales past 5Y0.00% Gross Margin- 52W Low388.15% ATR (14)0.58
Dividend Ex-Date- Current Ratio4.91 EPS Y/Y TTM18.54% Oper. Margin0.00% RSI (14)76.32 Volatility15.17% 12.29%
Employees75 Debt/Eq0.16 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price7.20
Option/ShortYes / Yes LT Debt/Eq0.15 EPS Q/Q34.38% Payout- Rel Volume1.08 Prev Close6.36
Sales Surprise- EPS Surprise-10.48% Sales Q/Q- EarningsNov 07 AMC Avg Volume632.90K Price6.59
SMA2038.44% SMA5096.69% SMA200159.16% Trades Volume683,420 Change3.62%
Date Action Analyst Rating Change Price Target Change
Feb-09-24Initiated BTIG Research Buy $8
Jan-23-24Initiated Leerink Partners Outperform $12
Sep-05-23Initiated RBC Capital Mkts Outperform $7
Nov-02-21Initiated Jefferies Buy $25
Nov-02-21Initiated Credit Suisse Outperform $19
Nov-02-21Initiated BofA Securities Neutral $16
Feb-27-24 08:00AM
Dec-29-23 04:30PM
Nov-28-23 07:00AM
Nov-07-23 04:30PM
Oct-23-23 11:27AM
09:00AM Loading…
Oct-13-23 09:00AM
Sep-27-23 09:18AM
Sep-14-23 05:03PM
Aug-31-23 04:01PM
Aug-23-23 08:35AM
Aug-11-23 07:00AM
Aug-01-23 04:01PM
Jun-30-23 05:00PM
May-30-23 08:30AM
May-24-23 06:45AM
07:00AM Loading…
May-11-23 07:00AM
Mar-31-23 05:00PM
Mar-30-23 02:16PM
Mar-22-23 06:45AM
Mar-16-23 07:30AM
Feb-13-23 08:00AM
Dec-23-22 04:45PM
Dec-01-22 06:45AM
Nov-01-22 06:30AM
Sep-30-22 05:00PM
Aug-15-22 07:00AM
Jul-12-22 06:45AM
Jun-28-22 06:35AM
Jun-21-22 10:40AM
May-19-22 06:35AM
08:03AM Loading…
May-13-22 08:03AM
May-07-22 10:34AM
Apr-27-22 06:35AM
Apr-13-22 06:35AM
Apr-08-22 01:05PM
Mar-29-22 11:00AM
06:35AM
Mar-22-22 06:35AM
Jan-10-22 11:17AM
Dec-15-21 08:00AM
Dec-09-21 08:30AM
Nov-15-21 07:15AM
Nov-10-21 08:00AM
Oct-08-21 03:31PM
Oct-07-21 10:24PM
Pyxis Oncology, Inc. engages in the business of developing a multi-modality portfolio of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. The firm focuses on the development of product candidates to directly kill tumor cells and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion. The company was founded by David Steinberg, Shaan C. Gandhi, and John L. Flavin on June 11, 2018 and is headquartered in Boston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Connealy Pamela AnnCFO and COOSep 28Buy1.878,00014,960818,532Sep 28 04:32 PM
Connealy Pamela AnnCFO and COOSep 27Buy1.856,42611,868810,532Sep 27 06:36 PM
Wadhane JitendraChief Accounting OfficerSep 27Buy1.872,5004,675226,937Sep 27 06:37 PM
Connealy Pamela AnnCFO and COOSep 25Buy1.6712,00020,044804,106Sep 25 05:04 PM
Wadhane JitendraChief Accounting OfficerSep 25Buy1.775,0008,850224,437Sep 25 05:05 PM
Connealy Pamela AnnCFO and COOSep 22Buy1.745,0008,695792,106Sep 22 07:34 PM
Wadhane JitendraChief Accounting OfficerSep 22Buy1.742,5004,349219,437Sep 22 07:35 PM
Sullivan LaraPresident and CEOSep 18Sale2.108,54117,9362,403,882Sep 18 07:03 PM
Sullivan LaraPresident and CEOSep 14Sale2.251002252,412,423Sep 18 07:03 PM
Sullivan LaraPresident and CEOSep 13Sale2.273,0006,8162,597,265Sep 13 08:16 PM
Sullivan LaraPresident and CEOSep 12Sale2.254,91711,0712,600,265Sep 13 08:16 PM
Sullivan LaraPresident and CEOSep 11Sale2.2720,00045,4142,605,182Sep 13 08:16 PM
PFIZER INC10% OwnerMar 17Buy2.761,811,5944,999,9995,952,263Mar 21 06:07 PM